Unraveling Common Patterns and Differences among Cruzipains through Molecular Dynamics Simulations and Structural

Lucianna Helene S Santos1, Augusto César Broilo Campos2, Viviane Corrêa Santos2

  • 1Institut Pasteur de Montevideo, Mataojo 2020, Montevideo 11400, Uruguay.

ACS Omega
|May 19, 2025
PubMed
Summary

Novel drug development for Chagas disease (CD) is crucial. Four Cruzipain subtypes show distinct active site features, suggesting varied substrate binding and potential for targeted therapies against this neglected tropical disease.